Tolerance for uncertainty and perceived risk among women receiving uninformative<i>BRCA1/2</i>test results
Suzanne C. O’Neill(Georgetown University), Marc D. Schwartz(Guardia Civil), Karen Brown(University of Leicester), Jessica Rispoli(Icahn School of Medicine at Mount Sinai), Heiðdís Valdimarsdóttir(Reykjavík University), Beth N. Peshkin(Georgetown University), Sarah Rogers(Georgetown University), Tiffani A. DeMarco(Georgetown University)
American Journal of Medical Genetics Part C Seminars in Medical Genetics
October 5, 2006
Cited by 77
Related Papers
The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening
|Preventive Medicine|2003|495
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
|PLoS ONE|2011|437
Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study
|The Lancet Psychiatry|2021|302
Randomized Noninferiority Trial of Telephone Versus In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer
|Journal of Clinical Oncology|2014|253
Impact of <i>BRCA1</i>/<i>BRCA2</i> Counseling and Testing on Newly Diagnosed Breast Cancer Patients
|Journal of Clinical Oncology|2004|250